Latest / The Psychology Undergrad Podcast / ADHD Medication & Alzheimer's Drugs: Stimulants, Atomoxetine & Memantine
Transcript
- 0:00Welcome to the psychology undergrad. You know,
- 0:03usually when we talk about a medical diagnosis,
- 0:05there is this this comforting expectation of
- 0:09precision. It feels kind of like engineering.
- 0:11Like you break your arm, the X -ray shows that
- 0:14jagged white line and the doctor just points
- 0:16to the screen and says, there it is. It's a binary
- 0:18system. It's either broken or not broken. It's
- 0:21clean. It's visible. And I mean, we as humans
- 0:24really crave things that can be easily. categorized
- 0:29and boxed up like that. Oh absolutely. But then
- 0:31you step into the world of neurodevelopment and
- 0:33neurodegeneration, and suddenly that X -ray machine
- 0:35is just entirely useless. Completely useless.
- 0:39We're looking at a diagnostic landscape that
- 0:41is honestly incredibly murky. So today we are
- 0:44doing a deep dive into the source material. A
- 0:46massive stack of sources you sent our way, actually.
- 0:49We've got clinical research papers, diagnostic
- 0:51manuals, your personal notes. That's quite a
- 0:53stack. It is. And our mission for you listening
- 0:56right now is to understand how two seemingly
- 0:59unrelated conditions. One neurodevelopmental,
- 1:03one neurodegenerative. How they both stem from
- 1:07invisible chemical imbalances and, you know,
- 1:10how pharmacology attempts to correct them. It
- 1:12is such a fascinating juxtaposition to explore.
- 1:15Because on one hand, you have ADHD, which is
- 1:18a condition where the brain's executive control
- 1:20systems are, well, they're struggling to properly
- 1:22come online during youth. Right. But then on
- 1:24the other hand, you have Alzheimer's disease.
- 1:26And that's where the incredibly complex neural
- 1:28networks we've spent an entire lifetime building
- 1:30are just tragically coming undone. OK, let's
- 1:33untack this. Because neither of these is classified
- 1:35strictly as a standard mental disorder. Right,
- 1:37they aren't. They are profound structural and
- 1:39chemical realities, just with massive behavioral
- 1:42consequences. OK, let's start with ADHD. Because
- 1:45I feel like this is a condition that gets talked
- 1:47about constantly in pop culture, but it's so
- 1:49rarely understood on an actual mechanical level.
- 1:52Oh, definitely. The misconceptions are everywhere.
- 1:54Right. So looking at the clinical data in our
- 1:56stack, ADHD affects roughly 9 % to 10 % of children
- 1:59and around 5 % of adults. But here is the kicker
- 2:02that immediately jumps out. Boys are three to
- 2:05four times more likely to be diagnosed than girls.
- 2:08Yeah, the disparity in those numbers is huge.
- 2:11So I have to ask the controversial question right
- 2:13out of the gate here. If boys are diagnosed at
- 2:15a rate that much higher, are we sure we aren't
- 2:17just pathologizing normal rambunctious childhood
- 2:20behavior? Like, are we essentially just medicalizing
- 2:22boyhood? You know, that is the exact question
- 2:24society wrestles with. And honestly, it's a totally
- 2:27fair skepticism to have when you're just looking
- 2:30at those surface numbers. Yeah. However, when
- 2:32you dig into the biological research, The evidence
- 2:34paints a very, very different picture. We are
- 2:37dealing with a structural neurological issue
- 2:39here, not a behavioral choice, and not just kids
- 2:42being kids. So it's not the old 1990s myths.
- 2:45It's not caused by eating too much sugar or watching
- 2:47too much television. Or bad parenting, right?
- 2:50No, not at all. The roots of ADHD go incredibly
- 2:53deep into genetic and epigenetic interactions
- 2:56combined with physical environmental factors.
- 2:59Like what kind of factors? The research points
- 3:01to physical stressors during critical developmental
- 3:04windows. So factors like premature birth where
- 3:08the brain hasn't had the full gestation period
- 3:10to to form its neural pathways. Oh wow. Yeah
- 3:13or prenatal exposure to acetaminophen or environmental
- 3:18toxins like lead. See what a fetal brain is developing.
- 3:22Neurons are literally migrating to their final
- 3:24destinations to form the prefrontal cortex and
- 3:26the reward centers. And if that migration gets
- 3:28messed up? Exactly. If toxins cross the placental
- 3:31barrier or if the birth is premature, that delicate
- 3:34migration and the subsequent wiring get interrupted.
- 3:36It's a fundamental alteration in how the brain's
- 3:39architecture is constructed. That makes the diagnostic
- 3:41criteria in the DSM -5 -TR make a lot more sense.
- 3:44It's not just a catch -all for bad behavior.
- 3:46No. The manual actually recognizes three distinct
- 3:49subtypes of ADHD. Right, and they require at
- 3:52least five out of nine specific symptoms to be
- 3:54present for over six months, which has to be
- 3:57completely outside of normal developmental phases.
- 3:59Which is a crucial distinction. It has to cause
- 4:02significant impairment in multiple settings,
- 4:05like both at home and at school, just to rule
- 4:08out a situational behavioral issue. And a great
- 4:12mental model to help you remember those three
- 4:14subtypes as we talk about them is the phrase,
- 4:17I have cats. That stands for inattentive, hyperactive,
- 4:21and combined. I have cats. That's a highly effective
- 4:24way to file that away. It really works. It perfectly
- 4:26encapsulates the predominantly inattentive type,
- 4:30the predominantly hyperactive impulsive type,
- 4:32and the combined type, where the patient exhibits
- 4:35significant symptoms of both. To truly understand
- 4:39why this isn't just pathologizing behavior, we
- 4:42have to look under the hood at the neurochemistry.
- 4:44Yes, here's where it gets really interesting.
- 4:46Because if you picture a hyperactive kid, the
- 4:48intuitive leap is that their brain has too much
- 4:51energy, too much stimulation, and it's just spilling
- 4:53over into physical movement. That is the assumption,
- 4:56yes. But the biological reality is the exact
- 4:59opposite. It's a deficit. We're looking at chronically
- 5:02low levels of dopamine and norepinephrine. Let's
- 5:06trace the dopamine first because it explains
- 5:08so much of the behavior. Okay, lay it out for
- 5:09us. So we have dopamine -producing neurons originating
- 5:12in a small structure deep in the midbrain. It's
- 5:15called the ventral tegmental area. or the VTA.
- 5:18The VTA, gone. Right. And these neurons project
- 5:21outward into the limbic system and the prefrontal
- 5:24cortex. This pathway is essentially our brain's
- 5:27core reward and motivation system. Okay, so what
- 5:30happens in ADHD? Well, when dopamine levels in
- 5:34this pathway are abnormally low due to those
- 5:36structural developmental issues we mentioned,
- 5:38the brain is basically starved for stimulation.
- 5:41It feels chronically under aroused. Oh, I see.
- 5:43So the classic hyperactivity, the constant fidgeting,
- 5:46the impulsivity, the inability to just sit quietly
- 5:49in a chair, that's not excess energy. Nope. That's
- 5:52the body trying to generate its own stimulation.
- 5:54You've hit the nail on the head. The brain requires
- 5:57a certain baseline level of arousal just to function
- 6:01comfortably. If it's not getting that internally
- 6:03from dopamine, it seeks it externally. So the
- 6:07child taps their foot or interrupts conversations.
- 6:09Or seeks out high -risk, high -reward activities
- 6:11just to get a localized dopamine hit. That beautifully
- 6:14explains the hyperactive impulsive subtype. Now
- 6:17we also have to factor in norepinephrine. Right,
- 6:20which governs the inattentive side of the disorder.
- 6:23Yes, norepinephrine neurons originate in a totally
- 6:25different brainstem area called the locus coeruleus,
- 6:28and they project heavily into the prefrontal
- 6:31cortex. Which is the area responsible for our
- 6:34executive function. Exactly. Now for those of
- 6:36you listening, locus coeruleus is Latin for blue
- 6:39spot. So a great way to lock this into your memory
- 6:42is to visualize focusing all of your intense
- 6:44attention on a single tiny blue spot. I like
- 6:48that. Yeah, that visualization links the locus
- 6:51coeruleus directly to its primary job, which
- 6:53is executive functions. We're talking about working
- 6:56memory, sustained attention, and the ability
- 6:58to tune out background noise. That's a powerful
- 7:01visualization. And taking that a step further,
- 7:05when neurokinect activity originating from that
- 7:08blue spot is too low, the prefrontal cortex simply
- 7:11cannot do its job. It just shuts down. Basically.
- 7:14The brain loses its biological ability to suppress
- 7:18random impulses and filter out irrelevant information.
- 7:22Everything feels equally important all at once.
- 7:24You know, it makes me think of the prefrontal
- 7:25cortex as an air traffic controller at a major
- 7:28airport. Oh, that's a good analogy. Right. Like
- 7:31when you have enough norepinephrine in, the controller
- 7:33is awake, focused and guiding every single thought,
- 7:37task and impulse to the correct runway in an
- 7:39orderly fashion. But without enough norepinephrine.
- 7:42That air traffic controller is essentially asleep
- 7:44at the desk. The planes, which are all the distractions,
- 7:48the sounds in the room, the random thoughts of
- 7:50the day, they just land wherever they want. It's
- 7:52total chaos in the terminal. That air traffic
- 7:55controller analogy perfectly illustrates why
- 7:57pharmacology approaches this the way it does,
- 8:00which brings us to what's often called the stimulant
- 8:02paradox. The stimulant paradox. Yeah. On the
- 8:06surface, it seems incredibly counterintuitive,
- 8:09I mean almost reckless, to give a hyperactive,
- 8:12bouncing -off -the -walls child a central nervous
- 8:14system stimulant like amphetamine. It really
- 8:17does. You have a kid who can't sit still and
- 8:20you hand them a powerful stimulant. It sounds
- 8:22like throwing gasoline on a fire. But... Because
- 8:25of what we just talked about, the understimulated
- 8:28starved brain, the stimulants actually act as
- 8:31the water that puts the fire out. How does that
- 8:33actually work mechanically though? Let's look
- 8:35at the mechanisms. First line treatments include
- 8:38amphetamines like Adderall or Methylphenidate.
- 8:41which you probably know as Ritalin or Concerta.
- 8:43Right, very common names. Think about the synapses,
- 8:45the gaps between neurons. Normally, after neurotransmitters
- 8:49do their job, transport proteins act like little
- 8:52vacuum cleaners to suck the chemicals back up.
- 8:55Okay. And phenamines actually reverse those transport
- 8:57proteins, forcing them to pump more neurotransmitters
- 9:00out into the synapse. Drugs like Ritalin take
- 9:03a slightly different approach. They act as reuptake
- 9:06inhibitors, essentially clogging the vacuum cleaners
- 9:08so the neurotransmitters stay in the synapse
- 9:10longer. Either way, the end result is a massive
- 9:14increase in the presence of dopamine and norepinephrine.
- 9:17You are finally giving that understimulated brain
- 9:20the chemical arousal it's been desperately seeking.
- 9:23And once the brain achieves that baseline level
- 9:25of stimulation internally, the physical hyperactivity
- 9:29stops. the brain no longer has to force the body
- 9:32to fidget to stay awake. The air traffic controller
- 9:35finally wakes up and gets back to routing the
- 9:37planes. That's nicely. Now, looking at our notes,
- 9:39there are second -line treatments, too, like
- 9:42Atomoxetine, sold as Stradara. This one stands
- 9:44out to me because it's a non -stimulant selective
- 9:47norepinephrine reuptake inhibitor. Right, an
- 9:50NRI. It doesn't trigger that massive dopamine
- 9:52release, meaning it has virtually zero potential
- 9:55for abuse, which parents and doctors obviously
- 9:57prefer. But the clinical data shows it's just
- 9:59not quite as universally effective for everyone
- 10:02as the classic stimulants. Which naturally leads
- 10:05us to explore the darker, more controversial
- 10:09side of these stimulant medications, the rampant
- 10:11misuse. Yes, the notorious study drugs. This
- 10:15brings up a really fascinating cultural and moral
- 10:18angle that I want to explore. Go for it. You
- 10:20look at college campuses or high -stress corporate
- 10:23environments, and there is this widespread misuse
- 10:27of Adderall by people who absolutely do not have
- 10:30ADHD. It's everywhere. And it feels heavily driven
- 10:33by this twisted modern version of the Protestant
- 10:36work ethic. You know, this deeply ingrained societal
- 10:39idea that hyperproductivity is next to godliness.
- 10:44So people take a chemical shortcut to achieve
- 10:47academic or professional salvation. They want
- 10:49to become emotionless, laser -focused productivity
- 10:52machines. Exactly. It's a massive cultural phenomenon.
- 10:55But psychologically and neurologically, it's
- 10:58built on a completely scientific fallacy, right?
- 11:00And absolutely is. When you examine the clinical
- 11:02trial data for these medications, stimulants
- 11:05only correct a cognitive deficit if a chemical
- 11:07imbalance is actually present to begin with.
- 11:09Wait, let me stop you there. Okay. Because the
- 11:11prevailing myth is that this is essentially a
- 11:13smart pill. Are you saying if you don't have
- 11:16ADHD, popping an Adderall doesn't actually enhance
- 11:19your cognition? The data strongly suggests it
- 11:21does not. Yeah. If your neurochemistry is intact
- 11:24and your dopamine and norepinephrine levels are
- 11:27normal, your executive functions, your air traffic
- 11:29controller, they are already operating at optimal
- 11:32capacity. The drug isn't upgrading your hardware
- 11:35or making you smarter. What is it doing then?
- 11:38What it is doing is triggering the underlying
- 11:40physiological stimulant properties of the amphetamine.
- 11:43So it's just keeping you awake? Precisely. It
- 11:46masks your body's natural fatigue signals. So
- 11:49instead of sleeping, you stay up for 14 hours
- 11:51cramming for a test or finishing a project. And
- 11:54then the student gets a high grade and swears
- 11:56the drug turned them into a genius. Exactly.
- 11:58But in reality, they just artificially force
- 12:01their body to endure a marathon of wakefulness.
- 12:05Meanwhile... They're putting themselves at risk
- 12:06for severe side effects, like dangerously high
- 12:09blood pressure, irregular heart rates, and in
- 12:12extreme cases, stimulant -induced psychosis.
- 12:15Wow. So they aren't achieving some higher state
- 12:17of intellect. They are quite literally just renting
- 12:20energy from tomorrow and paying for it with an
- 12:23incredibly high interest rate on their cardiovascular
- 12:25system. That's a great way to put it. And we
- 12:27can't discount the placebo effect either. The
- 12:30research notes that in healthy adults, any perceived
- 12:32cognitive improvement is largely just increased
- 12:36motivation and euphoria from the dopamine hit,
- 12:38coupled with a massive placebo effect. They feel
- 12:41like they're doing better work, even if the actual
- 12:44quality of the output hasn't improved at all.
- 12:47Right. It's a harsh but necessary reality check.
- 12:50It really is. OK, so we've spent the first half
- 12:53of this deep dive into the source material, looking
- 12:56at a brain struggling to build its executive
- 12:58control. But our sources take a sharp turn in
- 13:01the second half. They really do. We transition
- 13:03to a brain that is actively losing that control.
- 13:06We're moving from the neurodevelopmental world
- 13:08of ADHD to the neurodegenerative reality of Alzheimer's
- 13:12disease. It is one of the most devastating transitions
- 13:14in human biology. So what does this all mean?
- 13:17Let's break it down. Before we get into Alzheimer's
- 13:19specifically, we should define dementia. Good
- 13:21idea. Dementia isn't a specific disease. It's
- 13:26an umbrella term for a group of symptoms involving
- 13:29progressive disabling declines in memory, language
- 13:32and thinking. And Alzheimer's is simply the most
- 13:34common cause of those symptoms. Correct. It accounts
- 13:37for roughly 60 to 70 percent of all dementia
- 13:39cases. And just to round up the picture, the
- 13:42other types include vascular dementia, which
- 13:44is caused by physical blood supply issues like
- 13:47many strokes depriving the brain of oxygen and
- 13:50mixed dementia, which is exactly what it sounds
- 13:53like. Multiple causes co -occurring like Alzheimer's
- 13:56and vascular issues at the same time. But keeping
- 13:58our focus on Alzheimer's, a great mental model
- 14:02to help you grasp the principal symptoms is what
- 14:04neurologists call the four A's. Ah, yes, the
- 14:07four A's. They map perfectly onto the physical
- 14:10structural deterioration of the brain. Right.
- 14:12You have amnesia, which is the profound memory
- 14:15loss, apraxia, which is the loss of the ability
- 14:17to execute motor movements, even if the muscles
- 14:20themselves are fine. Then there's aphasia, the
- 14:23loss of speech and language comprehension. And
- 14:25agnosia, the inability to process sensory information,
- 14:28like failing to recognize a familiar face or
- 14:30an everyday object. The disease is relentless,
- 14:33progressing through three general stages, mild,
- 14:37moderate, and severe. Tragically, the typical
- 14:40life expectancy is only three to nine years after
- 14:42a formal diagnosis. That is so fast. And we usually
- 14:45associate it with the elderly, but the notes
- 14:47say five to 10 % are early onset. Yeah, early
- 14:50onset strikes patients before the age of 65.
- 14:52I'm looking at some of the brain scan comparisons
- 14:55in our research stack and the visual difference
- 14:58between a healthy brain and a severe Alzheimer's
- 15:01brain is absolutely terrifying. It's stark. You
- 15:03can see the physical volume of the brain has
- 15:05drastically shrunk. The cortex shrivels up and
- 15:08these massive gaps or ventricles form inside
- 15:10the brain. And the literature points out that
- 15:12it almost always attacks the hippocampus first.
- 15:15Why is the hippocampus so vulnerable? The hippocampus
- 15:18is essentially the brain's printing press for
- 15:20memory. It's responsible for consolidating short
- 15:23-term memories into long -term storage. Okay,
- 15:26so it's always working. Exactly. Because it's
- 15:28constantly doing this high -level complex processing,
- 15:31it has a very high metabolic demand. That makes
- 15:34it incredibly vulnerable to early damage. And
- 15:36what does that mean for the person? Well, when
- 15:38the hippocampus begins to physically deteriorate,
- 15:41the person loses the ability to form new memories
- 15:44and then slowly begins to lose their historical
- 15:46memories. The disease systematically erases a
- 15:50person's life history before spreading outward
- 15:53to the cortex to destroy their language and physical
- 15:56abilities. It's quite literally unwiring the
- 15:59individual. It is. And that unwiring doesn't
- 16:01just happen by magic. It is driven by two microscopic
- 16:05biological villains, amyloid plaques and neurofibrillary
- 16:09tangle. These are the pathological hallmarks
- 16:11of Alzheimer's disease. If you look at the brain
- 16:14tissue under a microscope, you see these two
- 16:16distinct anomalies wreaking havoc on the cellular
- 16:19level. OK, we need a way to visualize this so
- 16:21it sticks. Here's a fantastic mnemonic for you
- 16:24to use. Think of plaques on the porch and tangles
- 16:26in the living room. Plaques on the porch, tangles
- 16:29in the living room. Let's break that down. The
- 16:30porch represents the extracellular space, the
- 16:33area outside of the neuron. Amyloid plaques are
- 16:36hard, insoluble buildups of sticky amyloid beta
- 16:39protein fragments. In a healthy brain, these
- 16:42fragments are broken down and cleared away. In
- 16:45Alzheimer's, they accumulate on the porch outside
- 16:47the cells. And what happens when they build up?
- 16:49Do they just block the doorway? They do block
- 16:51cellular communication, but it's worse than that.
- 16:55These plaques are recognized by the brain's immune
- 16:57system as foreign invaders. Oh, no. Yeah. This
- 17:01triggers microglia, the brain's immune cells,
- 17:04to attack, causing chronic massive inflammation.
- 17:07That inflammation causes immense collateral damage
- 17:10to the surrounding healthy neurons. So that's
- 17:12the porch on fire. And then we move to the living
- 17:14room, which represents the inside of the cell.
- 17:16That's where you find the neurofibrillary tangles.
- 17:19Yes. Deep inside healthy neurons, you have these
- 17:21vital transport highways called microtubules.
- 17:24They carry nutrients and essential supplies from
- 17:26the cell body down to the synapses. OK. These
- 17:29highways are held together by structural supports
- 17:31called tau proteins. In Alzheimer's disease,
- 17:35a chemical change causes these proteins to become
- 17:37abnormal. They detach and collapse into each
- 17:40other. The tangles? Exactly. The microtubules
- 17:43completely break down into tangled, chaotic clumps
- 17:45of fibers. Without those transport highways,
- 17:48the cell can no longer move nutrients. It effectively
- 17:51starves to death from the inside out. It's a
- 17:54devastating dual front war. You have the plaques
- 17:56triggering immune attacks on the outside and
- 17:58the tangles starving the cell on the inside.
- 18:01It's incredibly destructive. But the destruction
- 18:04doesn't stop there. Our sources highlight two
- 18:06massive neurochemical hypotheses that explain
- 18:09the cognitive decline. The first is the cholinergic
- 18:13hypothesis. Right. This points to a severe, dramatic
- 18:16drop in acetylcholine in the hippocampus, which
- 18:19directly causes that amnesia and memory failure
- 18:21we talked about. And the second hypothesis, which
- 18:23is arguably even more destructive, involves a
- 18:26neurotransmitter called glutamate and a terrifying
- 18:29process known as excitotoxicity. Excitotoxicity
- 18:32is brutal. This part of the research genuinely
- 18:34blew my mind because glutamate is normally a
- 18:37good thing, right? It's our primary excitatory
- 18:39neurotransmitter. It helps neurons fire and communicate.
- 18:42It does. But when these neurons get damaged by
- 18:45the plaques and tangles, they malfunction and
- 18:47start dumping massive, uncontrolled amounts of
- 18:50glutamate into the brain. And that excess glutamate
- 18:53over activates specific receptors on the healthy
- 18:56surrounding cells, known as NMDA receptors. You
- 19:00can think of these NMDA receptors like floodgates
- 19:03on a dam. When glutamate opens them too wide
- 19:06and keeps them open too long, they allow a massive
- 19:09influx of calcium ions into the cell. And again,
- 19:12calcium is usually necessary for cellular function.
- 19:15But I've pictured this mechanism like drowning
- 19:17a house plant. You know your plant needs water
- 19:19to survive, so you give it a cup of water, and
- 19:21it thrives. Right. But if you take a high pressure
- 19:24fire hose and blast that plant with thousands
- 19:27of gallons of water, the flood completely destroys
- 19:29it. That massive flood of calcium into the neuron
- 19:32triggers an event called apoptosis. Apoptosis
- 19:35is programmed cell death. When the calcium levels
- 19:38get too high, it activates enzymes called proteases
- 19:41that literally begin to tear the cell apart from
- 19:43the inside. It tears itself apart. Yeah. The
- 19:46neuron detects the overwhelming damage and triggers
- 19:48its own internal self -destruct sequence to try
- 19:51and save the surrounding tissue. Excitotoxicity
- 19:55is essentially the brain aggressively pruning
- 19:57itself to death. So when we look at the pharmacology,
- 20:01when we look at Alzheimer's medications, we have
- 20:03to be clear. We aren't looking at cures. No.
- 20:06Definitely not. We are looking at drugs that
- 20:08attempt to block these specific mechanisms of
- 20:11destruction, just to buy the patient a little
- 20:13more time. It is entirely about slowing the inevitable
- 20:16decline. Yeah. For the mild to moderate stages
- 20:18of the disease, the first line of defense is
- 20:20cholinesterase inhibitors, with Dunpeazle being
- 20:23the most common. To understand how these work,
- 20:26think of them as Pac -Man blockers. Cholinesterase
- 20:28is an enzyme that naturally lives in the synapse,
- 20:31and its job is to eat up the leftover acetylcholine
- 20:34after a signal is sent. just like Pac -Man eating
- 20:37dots on a screen. That's a perfect way to picture
- 20:40it. But because Alzheimer's patients are desperately
- 20:42low on acetylcholine due to neuron death, we
- 20:45want to keep those dots around as long as possible
- 20:47to preserve whatever memory function is left.
- 20:50So the drug steps in and blocks Pac -Man. It
- 20:53inhibits the cholinesterase enzyme. This keeps
- 20:56acetylcholine floating in the synapse longer,
- 20:58amplifying the signal, and helping to stabilize
- 21:00the patient's memory temporarily. But, as you
- 21:03can guess, eventually so many neurons die that
- 21:06there simply isn't enough acetylcholine being
- 21:08produced for the Pac -Man blockers to make any
- 21:10difference at all. And that's when patients move
- 21:13into the moderate to severe stages. The pharmacological
- 21:16strategy shifts entirely. Doctors move to a drug
- 21:19called Mementine. And Mementine specifically
- 21:22tackles that drowning houseplant issue, doesn't
- 21:25it? It does. Mementine is classified as a non
- 21:28-competitive NMDA antagonist. It physically binds
- 21:32to those NMDA receptor channels and acts as a
- 21:34blockade. Just stops the flood. It limits the
- 21:36floodgates, reducing the massive influx of calcium
- 21:39into the cell. That doesn't stop the underlying
- 21:41disease process, but it dramatically slows down
- 21:44the excited toxicity. By preventing that calcium
- 21:46flood, it slows the rate of neuron death. Prolonging
- 21:49the window of time, a patient can maintain basic
- 21:51daily functions. Which brings us to the newest
- 21:54and easily the most controversial drug in our
- 21:57stack of research today. A dukinumab, marketed
- 22:00as a doolum. Ah, yes. It was approved in 2021
- 22:04and its mechanism is entirely different. It's
- 22:06a monoclonal antibody designed to physically
- 22:09target and remove those amyloid beta plaques
- 22:11from the porch. Theoretically, it's groundbreaking.
- 22:14It represents the first therapy attempting to
- 22:17target the underlying pathophysiology of Alzheimer's
- 22:21rather than just managing the downstream symptoms.
- 22:23But the controversy surrounding its approval
- 22:25is immense and highly documented. Very highly
- 22:28documented. The clinical trial data was incredibly
- 22:30conflicting on whether removing those plaques
- 22:33actually translated to any meaningful improvement
- 22:35in cognitive function for the patient. The data
- 22:38was so conflicting that an independent FDA advisory
- 22:41panel actually voted overwhelmingly against approving
- 22:43it. But the FDA went ahead and approved it anyway
- 22:46under an accelerated pathway. Which led to massive
- 22:49high profile resignations from that advisory
- 22:51panel. It's wild. And here is where we hit a
- 22:54profound ethical and moral crossroad in modern
- 22:57pharmacology. The manufacturer initially set
- 23:00the price of this drug at an astronomical $56
- 23:03,000 a year. It raises some of the most difficult
- 23:07ethical questions in medicine. You have a highly
- 23:10vulnerable population facing a terminal terrifying
- 23:13illness that slowly strips away their identity.
- 23:16The families are desperate for any shred of hope.
- 23:19And that's where the tension lies. Is it ethical
- 23:21to charge a desperate family $56 ,000 a year
- 23:24for a drug whose efficacy in actually restoring
- 23:27or preserving cognition is still so wildly unproven?
- 23:31It's a tough question. Where exactly does the
- 23:33line between providing genuine medical hope and
- 23:35engaging in financial exploitation lie? Because
- 23:37you have middle -class families willing to mortgage
- 23:40their homes or drain their retirement accounts
- 23:42just for a statistical chance at keeping their
- 23:44loved one's memory intact for a few years. more
- 23:45months. It perfectly encapsulates the painful
- 23:48reality of neuropharmacology. The scientific
- 23:51process moves incredibly slowly requiring years
- 23:54of rigorous data validation but human desperation
- 23:57and the suffering of these families is immediate.
- 23:59The ongoing debate over educanumab highlights
- 24:02the incredible tension between experimental medicine,
- 24:06corporate pricing structures, and the deeply
- 24:08human universal desire to save the mind of someone
- 24:12you love. It really does. It's a sobering thought.
- 24:14So as we wrap up this deep dive into the source
- 24:17material, we've seen how pharmacology attempts
- 24:20to reach in and manually adjust the complex styles
- 24:23of our brain chemistry. Exactly. Whether it's
- 24:25boosting dopamine and norepinephrine to help
- 24:27a restless, understimulated mind finally find
- 24:29focus. Or whether it's blocking rogue enzymes
- 24:32and calcium floods to try and preserve a fading
- 24:34memory against the ravages of time. We are, at
- 24:37our core, biological chemical machines, and these
- 24:40drugs are simply our tools attempting to keep
- 24:42the machine running as intended. And exploring
- 24:45that biology leads to a rather profound, lingering
- 24:47thought for you to take away. Oh. Yeah. We've
- 24:50spent this entire time talking about how physical
- 24:52neurotransmitters govern our attention, our impulses,
- 24:55and our memories. Those are the very things that
- 24:57shape our moral compass, our behaviors, and our
- 25:00fundamental sense of identity. So if a person's
- 25:03memory their personality and their behavior can
- 25:05be so fundamentally altered or temporarily restored
- 25:08simply by tweaking a dopamine pathway or blocking
- 25:11a calcium ion channel. It raises an incredible
- 25:14philosophical question. What's that? Are our
- 25:17unique personalities and our deepest moral convictions
- 25:19just a fragile temporary byproduct of our chemical
- 25:24balance? It is certainly something to think about
- 25:26the next time you feel completely intrinsically
- 25:28yourself. Wow. That is an incredibly heavy thought
- 25:31to leave on, but it's exactly why we dive into
- 25:34this research. The biology dictates the behavior.
- 25:37Thank you so much for joining us on this deep
- 25:39dive in the psychology undergrad. Keep questioning
- 25:41the world around you, keep exploring the science,
- 25:43and we will catch you on the next one.